Virtual Medicinal Product (VMP) - Doravirine 100mg / Lamivudine 300mg / Tenofovir disoproxil 245mg tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Doravirine 100mg / Lamivudine 300mg / Tenofovir disoproxil 245mg tablets Start Date 02-04-2025 End Date
Previous Name Previous Name Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets Start Date 18-03-2019 End Date 01-04-2025
Abbreviated Name Abbreviated Name Doravirine 100mg/Lamivudine 300mg/Tenofovir disoproxil 245mg Start Date 02-04-2025
Previous Abbreviated Name Lamivudine 300mg/Tenofovir disoproxil 245mg/Doravirine 100mg Previous Start Date 18-03-2019 Previous End Date 01-04-2025

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Name Basis
Other

Codes

ATC Code
J05AR24
BNF Codes
  • BNF code 05030100
SNOMED Codes
Code Start Date End Date
36903911000001101 18-03-2019

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Doravirine Based on Ingredient Substance 100 mg
Lamivudine Based on Ingredient Substance 300 mg
Tenofovir disoproxil Based on Ingredient Substance 245 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
30 tablet